Výsledky vyhledávání

Socioeconomic inequality in survival after oropharyngeal cancer - a nationwide study from DAHANCA

Autor: Olsen, M. H., Lassen, P., Rotbøl, C., Frederiksen, K., Kjær, T. K., Overgaard, J., Dalton, S. O.

Publikováno v: Olsen, M H, Lassen, P, Rotbøl, C, Frederiksen, K, Kjær, T K, Overgaard, J & Dalton, S O 2022, ' Socioeconomic inequality in survival after oropharyngeal cancer-a nationwide study from DAHANCA ', Radiotherapy and Oncology, vol. 170, no. Suppl. 1, pp. S814 . https://doi.org/10.1016/S0167-8140(22)02702-5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ecacd5587ce65ce673c0cb0c19657ae2
https://vbn.aau.dk/da/publications/27058e29-a393-4aba-a0bf-db0a019203b7

Zobrazit plný text záznamu

Greater event rates in high-risk patients with a history of heart disease: from the Systolic Blood Pressure Intervention Trial (SPRINT)

Autor: Pareek, M., Byrne, C., Mikkelsen, A. D., Kristensen, A. M. Dyrvig, Vaduganathan, M., Biering-Sorensen, T., Kragholm, K. H., Mortensen, M. B., Singh, A., Olsen, M. H., Bhatt, D. L.

Publikováno v: Pareek, M, Byrne, C, Mikkelsen, A D, Kristensen, A M D, Vaduganathan, M, Biering-Sorensen, T, Kragholm, K H, Mortensen, M B, Singh, A, Olsen, M H & Bhatt, D L 2021, ' Greater event rates in high-risk patients with a history of heart disease: from the Systolic Blood Pressure Intervention Trial (SPRINT) ', European Heart Journal, vol. 42, no. Suppl. 1, pp. 2313 . https://doi.org/10.1093/eurheartj/ehab724.2313

Background The Systolic Blood Pressure Intervention Trial (SPRINT) found that intensive versus standard blood pressure (BP) control reduced cardiovascular (CV) morbidity and mortality in patients at high CV risk. Effects were consistent among patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4735745c9d2ebb19ef722cf3595d6cc7
https://vbn.aau.dk/da/publications/212de8cd-8c6d-4975-8ebc-71bceb3fdf58

Zobrazit plný text záznamu

Central data monitoring in the multicentre randomised SafeBoosC-III trial:a pragmatic approach

Autor: Olsen, M. H., Hansen, M. L., Safi, S., Jakobsen, J. C., Greisen, G., Gluud, C., Pellicer, A., Bargiel, A., Hopper, A., Truttmann, A., Klamer, A., Heuchan, A. M., Memisoglu, A., Krolak-Olejnik, B., Rzepecka, B., Loureiro, B., Lecart, C., Hagmann, C., Ergenekon, E., Hatzidaki, E., Mastretta, E., Dempsey, E., Papathoma, E., Lou, F., Dimitriou, G., Pichler, G., Vento, G., Hahn, G. H., Naulaers, G., Cheng, G., Fuchs, H., Ozkan, H., De Las Cuevas, I., Sadowska-Krawczenko, I., Tkaczyk, J., Sirc, J., Zhang, J., Mintzer, J., De Buyst, J., Mccall, K., Bober, K., Sarafidis, K., Bender, L., Lopez, L. S., Chalak, L., Yang, L., Cornette, L., Arruza, L., Baserga, M., Stocker, M., Agosti, M., Cetinkaya, M., Alsina, M., Fumagalli, M., Suarez, O. L., Otero, O., Baud, O., Zafra, P., Agergaard, P., Maton, P., Viellevoye, R., del Rio Florentino, R., Lauterbach, R., Borregas, S. P., Nesargi, S., Rite, S., Rao, S., Zeng, S., Pisoni, S., Hyttel-Sorensen, S., Fredly, S., Oguz, S., Karen, T., Szczapa, T., Gao, X., Xu, X., Yin, Z.

Publikováno v: Olsen, M H, Hansen, M L, Safi, S, Jakobsen, J C, Greisen, G, Gluud, C, Pellicer, A, Bargiel, A, Hopper, A, Truttmann, A, Klamer, A, Heuchan, A M, Memisoglu, A, Krolak-Olejnik, B, Rzepecka, B, Loureiro, B, Lecart, C, Hagmann, C, Ergenekon, E, Hatzidaki, E, Mastretta, E, Dempsey, E, Papathoma, E, Lou, F, Dimitriou, G, Pichler, G, Vento, G, Hahn, G H, Naulaers, G, Cheng, G, Fuchs, H, Ozkan, H, De Las Cuevas, I, Sadowska-Krawczenko, I, Tkaczyk, J, Sirc, J, Zhang, J, Mintzer, J, De Buyst, J, McCall, K, Bober, K, Sarafidis, K, Bender, L, Lopez, L S, Chalak, L, Yang, L, Cornette, L, Arruza, L, Baserga, M, Stocker, M & The SafeBoosC-III Trial Group 2021, ' Central data monitoring in the multicentre randomised SafeBoosC-III trial : a pragmatic approach ', BMC Medical Research Methodology, vol. 21, 160 . https://doi.org/10.1186/s12874-021-01344-4
Olsen, M H, Hansen, M L, Safi, S, Jakobsen, J C, Greisen, G, Gluud, C & The SafeBoosC-III Trial Group 2021, ' Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach ', BMC Medical Research Methodology, vol. 21, no. 1, 160 . https://doi.org/10.1186/s12874-021-01344-4
Olsen, M H, Hansen, M L, Safi, S, Jakobsen, J C, Greisen, G, Gluud, C, The SafeBoosC-III Trial Group & Bender, L 2021, ' Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach ', BMC Medical Research Methodology, vol. 21, no. 1, 160 . https://doi.org/10.1186/s12874-021-01344-4
BMC Medical Research Methodology
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-10 (2021)

Background Data monitoring of clinical trials is a tool aimed at reducing the risks of random errors (e.g. clerical errors) and systematic errors, which include misinterpretation, misunderstandings, and fabrication. Traditional ‘good clinical pract

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f501ff427e360f947365182c541365
https://findresearcher.sdu.dk:8443/ws/files/190564776/Open_Access_Version.pdf

Zobrazit plný text záznamu

Socioeconomic inequality in survival after oropharynx cancer according to HPV-status: the impact of stage, smoking and comorbidity - a nationwide study from DAHANCA

Autor: Olsen, M. H., Lassen, P., Rotboel, C., Kjær, T. K., Frederiksen, K., Overgaard, J., Dalton, S. O.

Publikováno v: Olsen, M H, Lassen, P, Rotboel, C, Kjær, T K, Frederiksen, K, Overgaard, J, Dalton, S O & DAHANCA Group 2021, ' Socioeconomic inequality in survival after oropharynx cancer according to HPV-status: the impact of stage, smoking and comorbidity-a nationwide study from DAHANCA ', Oral Oncology, vol. 118, no. Suppl., pp. 11 . https://doi.org/10.1016/S1368-8375(21)00314-6

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::69942ee3bc06137684417907f2964686
https://vbn.aau.dk/da/publications/663c987e-893d-427d-80e9-080a9eb9c510

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání